Innate Pharma S.A. - American Depositary Shares — Cash Flow (NASDAQ:IPHA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities —————— — Cash from investing activities —————— — Cash from financing activities —————— — Free cash flow —————— —

News

Innate Pharma S.A. (IPHA) Discusses EUR 30 Million Equity Raise, Strategic Partnership and Pipeline Advancement Transcript

Innate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy - Innate

Innate Pharma Stock: Pipeline Optionality Favors Speculative Bulls At These Levels (IPHA)

Innate Pharma S.A. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2026-05-15

Innate Pharma S.A. (IPHA) Q1 2026 Earnings Call Transcript

Innate Pharma S.A. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2026-03-27

Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call Transcript

Innate Pharma S.A. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:IPHA) 2025-11-15

Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - BigBear.ai Hldgs (NYSE:BBAI), Aspire Biopharma Hldgs (NASDAQ:ASBP)

Innate Pharma (IPHA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Edwards Lifesciences (NYSE:EW), Brookfield Infr Partners (NYSE:BIP)

Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript